Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Site-specific integration into the genome refers to the precise insertion of genetic material at defined locations within a host organism’s DNA. This process is mediated by specialized enzymes, most notably site-specific recombinases or integrases, which recognize and act upon short, specific DNA sequences known as recombination sites. Unlike random integration methods—which can lead to unpredictable gene expression and potential disruption of essential genes—site-specific approaches enable controlled and predictable genetic modifications. Commonly used systems include Cre-loxP, PhiC31 integrase, and FLP-FRT.
Enzyme-mediated recombination at specific sequence motifs
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Genome (site-specific integration).